References
- American Academy of Sleep Medicine Task Force. (1999). Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:667–89.
- Atkeson A, Jelic S. (2008). Mechanisms of endothelial dysfunction in obstructive sleep apnea. Vasc Health Risk Manag 4:1327–35.
- Bhushan B, Khalyfa A, Spruyt K, et al. (2011). Fatty-acid binding protein 4 gene polymorphisms and plasma levels in children with obstructive sleep apnea. Sleep Med 12:666–71.
- Boscher C, Nabi IR. (2012). Caveolin-1: role in cell signaling. Adv Exp Med Biol 729:29–50.
- Bucci M, Gratton JP, Rudic RD, et al. (2000). In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med 6:1362–7.
- Chand S, Holle JU, Hilhorst M, et al. (2013). Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis. PLoS One 8:e69022.
- Dewan NA, Nieto FJ, Somers VK. (2015). Intermittent hypoxemia and OSA: implications for comorbidities. Chest 147:266–74.
- Epstein LJ, Kristo D, Strollo PJ Jr, et al. Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. (2009). Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 5:263–76.
- Gao Y, Zhao Y, Pan J, et al. (2014). Treadmill exercise promotes angiogenesis in the ischemic penumbra of rat brains through caveolin-1/VEGF signaling pathways. Brain Res 1585:83–90.
- Khalyfa A, Capdevila OS, Buazza MO, et al. (2009). Genome-wide gene expression profiling in children with non-obese obstructive sleep apnea. Sleep Med 10:75–86.
- Mathew R, Huang J, Gewitz MH. (2007). Pulmonary artery hypertension: caveolin-1 and eNOS interrelationship: a new perspective. Cardiol Rev 15:143–9.
- Mishra HK, Sharma SK, Sreenivas V. (2013). Angiotensin-converting enzyme gene polymorphism in north Indian population with obstructive sleep apnea. Sleep Breath 17:1029–37.
- Pelat M, Dessy C, Massion P, et al. (2003). Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E−/− mice in vivo. Circulation 107:2480–6.
- Pierola J, Alemany A, Yanez A, et al. (2011). NADPH oxidase p22phox polymorphisms and oxidative stress in patients with obstructive sleep apnoea. Respir Med 105:1748–54.
- Royce SG, Le Saux CJ. (2014). Role of caveolin-1 in asthma and chronic inflammatory respiratory diseases. Expert Rev Respir Med 8:339–47.
- Sambrook J, Fritsch EF, Maniatis T. (1982). Molecular clonning a laboratory manual, 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Lobısıcanory Press.
- Schwencke C, Braun-Dullaeus RC, Wunderlich C, Strasser RH. (2006). Caveolae and caveolin in transmembrane signaling: implications for human disease. Cardiovasc Res 70:42–9.
- Thomas CM, Smart EJ. (2008). Caveolae structure and function. J Cell Mol Med 12:796–809.
- Varvarigou V, Dahabreh IJ, Malhotra A, Kales SN. (2011). A review of genetic association studies of obstructive sleep apnea: field synopsis and meta-analysis. Sleep 34:1461–8.
- Williams TM, Lisanti MP. (2004). The caveolin proteins. Genome Biol 5:214.